Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Attune Health Research, Inc.
With
Horizon Pharma Ireland, Ltd., Dublin Ireland
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
1. Adult patients with gout diagnosed by a Rheumatologist.
2. patients with a history of at least two gout attacks in the target joint
3. Patients with a target joint amenable to biopsy. Target joint defined as:
Joint that has been affected by acute gout attack at least twice in the 12 months prior to enrollment.
Ultrasound finds grade 2 gray-scale synovitis in joint. Joint is amenable to biopsy. At the time of enrollment, the joint is without signs of acute inflammation: redness, swelling, and severe pain (\>7/10).
You may not be if
1. Patients on anti-coagulation therapy.
2. Patients with an active infection.
3. Tophus present at the biopsy site.
4. Target joint with signs of acute gout attack (pain \>7/10, redness, warmth)
5. Known chondrocalcinosis
Clareo Health | Assessing the Role of the NLRP3 Inflammasome in Intercritical Gout
